Floatz logo

Therapeutic Asset Ratings

278 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Zanidatamab
Metastatic Neoplasm
QuantumLeap Healthcare CollaborativeP1CC (43)
Zanidatamab
Progesterone-Receptor Positive Breast Cancer
QuantumLeap Healthcare CollaborativeP1CC (43)
Zanidatamab
PR-positive Breast Cancer
QuantumLeap Healthcare CollaborativeP1CC (43)
Evorpacept
Metastatic Malignant Neoplasm
QuantumLeap Healthcare CollaborativeP1CC (42)
Evorpacept
Carcinoma
QuantumLeap Healthcare CollaborativeP1CC (41)
Fam-Trastuzumab Deruxtecan-Nxki
Carcinoma
QuantumLeap Healthcare CollaborativeP1CC (41)
Tucatinib
Carcinoma
QuantumLeap Healthcare CollaborativeP1CC (41)
Zanidatamab
Carcinoma
QuantumLeap Healthcare CollaborativeP1CC (41)
Amcenestrant
Angiosarcoma
QuantumLeap Healthcare CollaborativeP2C (39)
Amcenestrant
Breast Neoplasm
QuantumLeap Healthcare CollaborativeP2C (39)
Amcenestrant
Her2-Receptor Negative Breast Cancer
QuantumLeap Healthcare CollaborativeP2C (39)
Amcenestrant
HER2 Positive Breast Carcinoma
QuantumLeap Healthcare CollaborativeP2C (39)
Amcenestrant
Hormone Receptor Negative Tumor
QuantumLeap Healthcare CollaborativeP2C (39)
Amcenestrant
Hormone Receptor Positive Tumor
QuantumLeap Healthcare CollaborativeP2C (39)
Amcenestrant
Triple-Negative Breast Carcinoma
QuantumLeap Healthcare CollaborativeP2C (39)
Evorpacept
Solid Tumor
QuantumLeap Healthcare CollaborativeP1C (39)
Fam-Trastuzumab Deruxtecan-Nxki
Metastatic Malignant Neoplasm
QuantumLeap Healthcare CollaborativeP1C (39)
Tucatinib
Metastatic Malignant Neoplasm
QuantumLeap Healthcare CollaborativeP1C (39)
Zanidatamab
Metastatic Malignant Neoplasm
QuantumLeap Healthcare CollaborativeP1C (39)
Evorpacept
Her2-Receptor Negative Breast Cancer
QuantumLeap Healthcare CollaborativeP1C (37)
Evorpacept
HER2 Positive Breast Carcinoma
QuantumLeap Healthcare CollaborativeP1C (37)
Evorpacept
Solid Tumor, Adult
QuantumLeap Healthcare CollaborativeP1C (37)
Evorpacept
Triple-Negative Breast Carcinoma
QuantumLeap Healthcare CollaborativeP1C (37)
Fam-Trastuzumab Deruxtecan-Nxki
Her2-Receptor Negative Breast Cancer
QuantumLeap Healthcare CollaborativeP1C (37)
Fam-Trastuzumab Deruxtecan-Nxki
Solid Tumor, Adult
QuantumLeap Healthcare CollaborativeP1C (37)
Showing 251 to 275 of 278 assets
PreviousPage 11 of 12Next